Gryphon Financial Partners LLC Evogene Ltd. Transaction History

Gryphon Financial Partners LLC

  • $736 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 06, 2018
SELL
$2.6 - $3.14 $65 - $78
-25 Closed
0 $0
Q1 2018

May 14, 2018
SELL
$3.15 - $4.16 $708 - $936
-225 Reduced 90.0%
25 $0
Q4 2017

Feb 09, 2018
BUY
$3.07 - $4.68 $767 - $1,170
250
250 $1,000

Others Institutions Holding EVGN

# of Institutions
1
Shares Held
117K
Call Options Held
0
Put Options Held
0
View Full List

About Evogene Ltd.

EVGN Quotes by TradingView
  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $69.6M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Gryphon Financial Partners LLC Portfolio

Follow Gryphon Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gryphon Financial Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email